Improvement of anti-muscle-specific receptor tyrosine kinase antibody-positive myasthenia gravis with dysphagia after combination immunotherapy: A case report

INTRODUCTION: In adult patients, anti-muscle-specific receptor tyrosine kinase antibody-positive myasthenia gravis (MuSK-MG) frequently presents with bulbar symptoms and tends to progress to myasthenic crisis, although data in pediatric patients are limited. Pediatric-onset MuSK-MG is rare, and a standard treatment approach has not been established. Here, we report a pediatric-onset case of MuSK-MG in which combination immunotherapy improved symptoms, including dysphagia. CASE PRESENTATION: A 15-year-old girl presented with diplopia that had begun 2 years prior, followed by gradual worsening of dysphagia and dysarthria. A videofluoroscopic swallowing study (VFSS) demonstrated inadequate soft palate elevation, poor pharyngeal contraction, repeated swallowing, laryngeal penetration, and residue in the epiglottic vallecula and pyriform sinus. She tested positive for anti-muscle-specific receptor tyrosine kinase antibodies (anti-MuSK antibodies) and was diagnosed with MuSK-MG. Treatment with intravenous immunoglobulin, intravenous methylprednisolone, and oral prednisolone and tacrolimus led to improvement in her symptoms, including dysphagia, starting 3 weeks after initiation. CONCLUSION: MuSK-MG may be responsive to treatment even 2 years after symptom onset. Anti-MuSK antibodies testing should be considered in patients with progressive dysphagia and dysarthria, particularly when bulbar symptoms are unexplained. VFSS was useful for objectively assessing the severity of dysphagia and its improvement.

Authors

Institutions

Publication Details

Journal
Brain and Development
Published
2026-11-17
DOI
https://doi.org/10.1016/j.braindev.2026.104620
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Improvement of anti-muscle-specific receptor tyrosine kinase antibody-positive myasthenia gravis with dysphagia after combination immunotherapy: A case report

Eri Takeshita, Yuko Shimizu‐Motohashi, Eiichiro Nagata, 由美 佐藤 et al.
Brain and Development
Myasthenia Gravis and Thymoma
article

Improvement of anti-muscle-specific receptor tyrosine kinase antibody-positive myasthenia gravis with dysphagia after combination immunotherapy: A case report

Eri Takeshita, Yuko Shimizu‐Motohashi, Eiichiro Nagata, 由美 佐藤, Hirofumi Komaki, Takayuki Handa, Keiko Ishigaki, Toshiyuki Yamamoto
article en

Abstract

INTRODUCTION: In adult patients, anti-muscle-specific receptor tyrosine kinase antibody-positive myasthenia gravis (MuSK-MG) frequently presents with bulbar symptoms and tends to progress to myasthenic crisis, although data in pediatric patients are limited. Pediatric-onset MuSK-MG is rare, and a standard treatment approach has not been established. Here, we report a pediatric-onset case of MuSK-MG in which combination immunotherapy improved symptoms, including dysphagia. CASE PRESENTATION: A 15-year-old girl presented with diplopia that had begun 2 years prior, followed by gradual worsening of dysphagia and dysarthria. A videofluoroscopic swallowing study (VFSS) demonstrated inadequate soft palate elevation, poor pharyngeal contraction, repeated swallowing, laryngeal penetration, and residue in the epiglottic vallecula and pyriform sinus. She tested positive for anti-muscle-specific receptor tyrosine kinase antibodies (anti-MuSK antibodies) and was diagnosed with MuSK-MG. Treatment with intravenous immunoglobulin, intravenous methylprednisolone, and oral prednisolone and tacrolimus led to improvement in her symptoms, including dysphagia, starting 3 weeks after initiation. CONCLUSION: MuSK-MG may be responsive to treatment even 2 years after symptom onset. Anti-MuSK antibodies testing should be considered in patients with progressive dysphagia and dysarthria, particularly when bulbar symptoms are unexplained. VFSS was useful for objectively assessing the severity of dysphagia and its improvement.

Brain and DevelopmentVol. 48(6)
National Center of Neurology and Psychiatry (JP), Tokai University Hospital (JP), Tokyo Women's Medical University (JP), Isehara Kyodo Hospital (JP), National Center Hospital of Neurology and Psychiatry (JP), Translational Medical Center, National Center of Neurology and Psychiatry (JP)
National Center of Neurology and Psychiatry
Good health and well-being
Myasthenia Gravis and Thymoma
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon